NR 606 Final Exam Practice Questions
and Answers with Rationales 2026
Diagnosis and Management in Psychiatric
Mental Health II Practicum Pass Your
Chamberlain NR 606 Final with
Confidence
TABLE OF CONTENTS
| Section | Topic | Questions |
| :--- | :--- | :--- |
| 1 | ADHD Pharmacotherapy and Management | 1 to 25 |
| 2 | Eating Disorders | 26 to 45 |
| 3 | Trauma, PTSD, and FASD | 46 to 60 |
| 4 | Pediatric Mental Health Disorders | 61 to 80 |
| 5 | Perinatal Psychiatry and Psychopharmacology | 81 to 95 |
| 6 | Comprehensive PMHNP Review | 96 to 150 |
SECTION 1: ADHD PHARMACOTHERAPY AND
MANAGEMENT
,Question 1
A 9-year-old child is started on methylphenidate extended-release for
ADHD. The parents report the child is having trouble falling asleep.
What is the most appropriate initial intervention
A. Discontinue the medication immediately
B. Add trazodone 25 mg at bedtime
C. Administer the medication earlier in the day
D. Switch to a non-stimulant medication
Correct Answer C
Rationale Administering the medication earlier in the day is the most
appropriate initial intervention for stimulant-induced insomnia. This
allows the medication levels to decrease before bedtime. Discontinuing
the medication is not necessary. Adding trazodone or switching to a non-
stimulant are not first-line interventions for managing insomnia caused
by stimulants .
Question 2
Which laboratory test should be obtained before starting atomoxetine
,A. Complete blood count
B. Liver function tests
C. Electrocardiogram
D. Basic metabolic panel
Correct Answer B
Rationale Atomoxetine carries an FDA black box warning for rare but
severe hepatotoxicity. Baseline liver function tests are recommended
before initiation and periodically during treatment. ECG is indicated for
stimulants with cardiac history. CBC and BMP are not specifically
required before starting atomoxetine .
Question 3
A 7-year-old with ADHD and a history of seizure disorder controlled on
levetiracetam. Which ADHD medication is safest
A. Bupropion
B. Atomoxetine
C. Methylphenidate
D. Amphetamine-dextroamphetamine
Correct Answer C
, Rationale Methylphenidate does not lower the seizure threshold and is
considered safe in children with well-controlled epilepsy. Bupropion
significantly lowers seizure threshold and is contraindicated in seizure
disorders. Atomoxetine and amphetamines may also lower seizure
threshold .
Question 4
A 16-year-old with ADHD and a history of substance use disorder
requires pharmacotherapy. Which agent is most appropriate
A. Adderall IR
B. Ritalin IR
C. Atomoxetine
D. Dexedrine spansules
Correct Answer C
Rationale Atomoxetine is a non-stimulant medication with no abuse
potential, making it the most appropriate choice for patients with a
history of substance use disorder. Stimulants have abuse potential and
are contraindicated in active substance use disorder .
Question 5
and Answers with Rationales 2026
Diagnosis and Management in Psychiatric
Mental Health II Practicum Pass Your
Chamberlain NR 606 Final with
Confidence
TABLE OF CONTENTS
| Section | Topic | Questions |
| :--- | :--- | :--- |
| 1 | ADHD Pharmacotherapy and Management | 1 to 25 |
| 2 | Eating Disorders | 26 to 45 |
| 3 | Trauma, PTSD, and FASD | 46 to 60 |
| 4 | Pediatric Mental Health Disorders | 61 to 80 |
| 5 | Perinatal Psychiatry and Psychopharmacology | 81 to 95 |
| 6 | Comprehensive PMHNP Review | 96 to 150 |
SECTION 1: ADHD PHARMACOTHERAPY AND
MANAGEMENT
,Question 1
A 9-year-old child is started on methylphenidate extended-release for
ADHD. The parents report the child is having trouble falling asleep.
What is the most appropriate initial intervention
A. Discontinue the medication immediately
B. Add trazodone 25 mg at bedtime
C. Administer the medication earlier in the day
D. Switch to a non-stimulant medication
Correct Answer C
Rationale Administering the medication earlier in the day is the most
appropriate initial intervention for stimulant-induced insomnia. This
allows the medication levels to decrease before bedtime. Discontinuing
the medication is not necessary. Adding trazodone or switching to a non-
stimulant are not first-line interventions for managing insomnia caused
by stimulants .
Question 2
Which laboratory test should be obtained before starting atomoxetine
,A. Complete blood count
B. Liver function tests
C. Electrocardiogram
D. Basic metabolic panel
Correct Answer B
Rationale Atomoxetine carries an FDA black box warning for rare but
severe hepatotoxicity. Baseline liver function tests are recommended
before initiation and periodically during treatment. ECG is indicated for
stimulants with cardiac history. CBC and BMP are not specifically
required before starting atomoxetine .
Question 3
A 7-year-old with ADHD and a history of seizure disorder controlled on
levetiracetam. Which ADHD medication is safest
A. Bupropion
B. Atomoxetine
C. Methylphenidate
D. Amphetamine-dextroamphetamine
Correct Answer C
, Rationale Methylphenidate does not lower the seizure threshold and is
considered safe in children with well-controlled epilepsy. Bupropion
significantly lowers seizure threshold and is contraindicated in seizure
disorders. Atomoxetine and amphetamines may also lower seizure
threshold .
Question 4
A 16-year-old with ADHD and a history of substance use disorder
requires pharmacotherapy. Which agent is most appropriate
A. Adderall IR
B. Ritalin IR
C. Atomoxetine
D. Dexedrine spansules
Correct Answer C
Rationale Atomoxetine is a non-stimulant medication with no abuse
potential, making it the most appropriate choice for patients with a
history of substance use disorder. Stimulants have abuse potential and
are contraindicated in active substance use disorder .
Question 5
